Nanospas 80mg/250mg Tablet
Marketer
Nanos Medicare Pvt. Ltd.
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Nanospas 80mg/250mg Tablet
Abdominal pain relief is provided by the combined medication, Gastrocalm 80mg/250mg Tablet. This formulation eases abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Gastrocalm 80mg/250mg Tablets should be taken with meals, following your physician's prescribed dosage and duration. Dosage is individualized based on your response and condition; continued use, as directed, is crucial to prevent symptom recurrence and potential worsening. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common, typically transient, side effects include nausea, vomiting, diarrhea, stomach pain, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential increased dizziness. Consult your doctor prior to use if you are pregnant, breastfeeding, or planning pregnancy; likewise, disclose any kidney or liver conditions to ensure appropriate dosage.
Primary Ingredients of Nanospas 80mg/250mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Nanospas 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Nanospas 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Nanospas 80mg/250mg tablets should be administered with a meal.
Common Side effects of Nanospas 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Nanospas 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Nanospas 80mg/250mg Tablet should be administered with a meal.
How Nanospas 80mg/250mg Tablet works:
Nanospas 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets and reduces painful muscle contractions in the abdomen. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of substances triggering abdominal pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Nanospas 80mg/250mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Nanospas 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Consult your doctor for guidance.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Nanospas 80mg/250mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Nanospas 80mg/250mg Tablets, a potential side effect of the medication; vertigo is one such possibility.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Nanospas 80mg/250mg tablets, as dose modification may be necessary. Medical advice is recommended. Nanospas 80mg/250mg tablets are contraindicated in patients with severely compromised kidney function.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Nanospas 80mg/250mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nanospas 80mg/250mg Tablet :
Should you forget to take a Nanospas 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nanospas 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently